Co-Amvasc Hct 5/160/12.5 28 Tablets

Co-Amvasc HCT 5/160/12.5mg Tablets (28-pack) contain amlodipine 5mg, valsartan 160mg, and hydrochlorothiazide 12.5mg — a triple-combination antihypertensive used in the management of hypertension in adults requiring multi-mechanism blood pressure control. PENDING PHARMACIST REVIEW

Co-Amvasc HCT 5/160/12.5 is a fixed-dose triple-combination antihypertensive tablet combining a calcium channel blocker, ARB, and thiazide diuretic for effective multi-mechanism blood pressure management. PENDING PHARMACIST REVIEW Benefits: • Amlodipine (calcium channel blocker) relaxes arterial smooth muscle to reduce peripheral resistance • Valsartan (ARB) blocks angiotensin II to reduce vasoconstriction and aldosterone secretion • Hydrochlorothiazide promotes renal sodium excretion, reducing blood volume and pressure • Fixed triple combination improves patient adherence compared to taking three separate tablets • Indicated in patients requiring multiple antihypertensive agents for adequate BP control How To Use: Take exactly as prescribed by a physician. Swallow the tablet whole with water, with or without food. Do not discontinue without medical advice. Monitor blood pressure regularly. Report dizziness, swelling, or significant blood pressure changes to your doctor immediately.